-
1Academic Journal
المؤلفون: Branislava Raičević, Ivana Stević, Dragana Lakić, Agnes Männik, Kalina Gjorgjievska, Bojan Labachevski, Kristina Pavlovska, Miodrag Žunić, Petya Milushewa, Guenka Petrova, Dominik Grega, Przemysław Holko, Slobodan M. Janković
المصدر: Biotechnology & Biotechnological Equipment, Vol 38, Iss 1 (2024)
مصطلحات موضوعية: Anti-obesity drugs, adverse effects, costs, economic evaluation, Biotechnology, TP248.13-248.65
وصف الملف: electronic resource
-
2Academic Journal
المؤلفون: Mailhac A, Pedersen L, Pottegård A, Søndergaard J, Mogensen T, Sørensen HT, Thomsen RW
المصدر: Clinical Epidemiology, Vol Volume 16, Pp 307-318 (2024)
مصطلحات موضوعية: drug utilization, epidemiology, anti-obesity drugs, glucose-lowering drugs, obesity, type 2 diabetes, Infectious and parasitic diseases, RC109-216
وصف الملف: electronic resource
-
3Academic Journal
المؤلفون: Matheo A. M. Stumpf, Marcio C. Mancini
المصدر: Archives of Endocrinology and Metabolism, Vol 68 (2024)
مصطلحات موضوعية: Bariatric surgery, GLP-1 receptor agonists, mortality, extreme obesity, anti-obesity drugs, Medicine, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
وصف الملف: electronic resource
-
4Academic Journal
المؤلفون: Walmir Coutinho, Bruno Halpern
المصدر: Diabetology & Metabolic Syndrome, Vol 16, Iss 1, Pp 1-16 (2024)
مصطلحات موضوعية: Obesity, Weight loss, Anti-obesity drugs, Sibutramine, Orlistat, GLP-1 analogs, Nutritional diseases. Deficiency diseases, RC620-627
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1758-5996
-
5Academic Journal
المؤلفون: Polovina Snežana, Šumarac-Dumanović Mirjana, Micić Dragan
المصدر: Arhiv za farmaciju, Vol 74, Iss 3, Pp 335-347 (2024)
مصطلحات موضوعية: obesity, dietary treatment, exercise, anti-obesity drugs, bariatric surgery, low grade inflammation, Pharmacy and materia medica, RS1-441
وصف الملف: electronic resource
-
6Academic Journal
المؤلفون: A. V. Vitebskaya, A. V. Popovich
المصدر: Ожирение и метаболизм, Vol 20, Iss 2, Pp 124-130 (2023)
مصطلحات موضوعية: anti obesity drugs, liraglutide, adolescents, gastrointestinal diseases, Physiology, QP1-981, Biochemistry, QD415-436
وصف الملف: electronic resource
-
7Academic Journal
المؤلفون: Elena Domingo, Patrice Marques, Vera Francisco, Laura Piqueras, Maria-Jesus Sanz
المصدر: Pharmacological Research, Vol 200, Iss , Pp 107058- (2024)
مصطلحات موضوعية: Hypercholesterolemia, Obesity, Endothelial dysfunction, Lipid-lowering therapies, Anti-obesity drugs, Anti-inflammatory effects, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
8Academic Journal
المؤلفون: Mailhac, Aurélie, Pedersen, Lars, Pottegård, Anton, Søndergaard, Jens, Mogensen, Torben, Sørensen, Henrik Toft, Thomsen, Reimar W.
المصدر: Mailhac , A , Pedersen , L , Pottegård , A , Søndergaard , J , Mogensen , T , Sørensen , H T & Thomsen , R W 2024 , ' Semaglutide (Ozempic®) Use in Denmark 2018 Through 2023 ‒ User Trends and off-Label Prescribing for Weight Loss ' , Clinical epidemiology , vol. 16 , pp. 307-318 . https://doi.org/10.2147/CLEP.S456170
مصطلحات موضوعية: anti-obesity drugs, drug utilization, epidemiology, glucose-lowering drugs, obesity, type 2 diabetes
-
9Academic Journal
المؤلفون: Hernández-Rodríguez, José
المصدر: Revista de ciencias médicas de Pinar del Río; Vol. 28 (2024): (Sistema de Publicación Continua); e6164 ; 1561-3194
مصطلحات موضوعية: QUITOSANO, OBESIDAD, FÁRMACOS ANTI-OBESIDAD. obesidad, fármacos anti-obesidad, CHITOSAN, OBESITY, ANTI-OBESITY DRUGS
وصف الملف: application/pdf
Relation: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/6164/pdf; https://revcmpinar.sld.cu/index.php/publicaciones/article/downloadSuppFile/6164/1660; https://revcmpinar.sld.cu/index.php/publicaciones/article/downloadSuppFile/6164/1794; Gómez JC, Ena J, Lorido JA, Ripoll JS, Carrasco FJ, Gómez R, et al. La obesidad es una enfermedad crónica. Posicionamiento del grupo de trabajo de Diabetes, Obesidad y Nutrición de la Sociedad Española de Medicina Interna (SEMI) por un abordaje centrado en la persona con obesidad. Revista Clínica Española [Internet]. 2021 [Citado 18/08/2023]; 221(9): 509-16. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0014256520301806; Pablo AM, García R, Leija G. Tratamiento farmacológico de la obesidad. Humanidades, tecnología y ciencia, del Instituto Politécnico Nacional [Internet]. 2020 [Citado 18/08/2023]; 22: 1-13. Disponible en: http://revistaelectronica-ipn.org/ResourcesFiles/Contenido/23/CIENCIA_23_000869.pdf; Di Marco MV, Posadas L, Valentí LL, Barrionuevo E, Bichara P, Incarbone O, et al. Guía de Práctica Clínica Nacional sobre Diagnóstico y Tratamiento de la Obesidad en adultos para todos los niveles de atención [Internet]. Ministerio de Salud, Presidencia de la Nación (Argentina); 2017 [Citado 12/07/23]. Disponible en: https://iah.salud.gob.ar/doc/Documento3.pdf; Rubio MA. Nuevas aproximaciones farmacológicas al tratamiento de la obesidad. Nutr Clin Med [Internet]. 2022 [Citado 12/7/23]; XVI(3): 179-94. Disponible en: https://nutricionclinicaenmedicina.com/wp-content/uploads/2022/12/5114.pdf; Agencia española de medicamentos y productos sanitarios. Ficha técnica Saxenda 6 mg/ml solución inyectable en pluma precargada [Internet]. CIMA; 2019 [citado 12/6/23]. Disponible en: https://cima.aemps.es/cima/dochtml/ft/115992003/FT_115992003.html#3; VADEMECUM. Semaglutida [Internet]. España; 2021 [Citado 02/07/2022]. Disponible en: https://www.vademecum.es/principios-activos-semaglutida-A10BJ06; Hernández J. La semaglutida en el tratamiento de las personas con diabesidad. Revista Cubana de Medicina [Internet]. 2023 [Citado 12/7/23]; 62(1). Disponible en: https://revmedicina.sld.cu/index.php/med/article/view/2946; Clément K, van den Akker E, Argente J, Bahm A, Chung WK, Connors H, et al. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol [Internet]. 2020 [Citado 12/7/23]; 8(12): 960-70. Disponible en: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30364-8/fulltext; Navarro M, Jáuregui I. Tratamiento farmacológico de la obesidad. JONNPR [Internet]. 2020 [Citado 03/07/2023]; 5(12): 1464-69. Disponible en: https://jonnpr.com/PDF/3636.pdf; DAILYMED. Qsymia - phentermine and topiramate capsule, extended reléase. National Library of Medicine (NIH) [Internet]. AILYMED; 2022 [Citado 12/07/23]. Disponible en: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40dd5602-53da-45ac-bb4b-15789aba40f9#S1; Aymara A, Nathaly P. Estudio de la hepatotoxicidad inducida por la ingesta de productos adelgazantes [Tesis]. Quito; 2022 [Citado 22/07/23]. Disponible en: http://www.dspace.uce.edu.ec/bitstream/25000/29585/1/UCE-FCQ-CBC-AGUIRRE%20PAMELA.pdf; Hernández J, Orlandis N. Spirulina platensis en el tratamiento de la obesidad y de algunas de sus consecuencias. Rev Cubana Med Gen Integr [Internet]. 2021 [Citado 18/08/2023]; 37(3): e1508. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252021000300016&lng=es.; Hernández J. Spirulina as a natural product with potentials for its use in patients with diabetes mellitus. Rev Cubana Endocrinol [Internet]. 2021 [Citado 18/08/2023]; 32(1): e247. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532021000100009&lng=es.; Hernández J, Iglesias I. Effects of Moringa oleifera on Human Health. Rev Cubana Med Gen Integr [Internet]. 2022 [Citado 18/08/2023]; 38(1): e1682. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252022000100017&lng=es.; Hernández J, Iglesias I. Moringa oleifera: un producto natural con posibilidades para ser usado en pacientes con diabetes mellitus. Rev Cubana Endocrinol [Internet]. 2021 [accedido 18/8/2023]; 32(1): e273. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532021000100011&lng=es.; Sutthasuphaa P, Lungkaphin A. Las funciones potenciales del oligosacárido de quitosano en la prevención de la lesión renal en condiciones de obesidad y diabetes. Food & Function [Internet]. 2020 [Citado 18/08/2023]; 11(9): 7371-88. Disponible en: https://pubs.rsc.org/en/content/articlelanding/2020/fo/d0fo00302f/unauth; Navarro R. Chitosán: qué es y para qué sirve [Internet]. Mifarma; 2022 [Citado 18/08/2023]. Disponible en: https://www.atida.com/es-es/blog/diccionario-farmacia/chitosan/; Huq T, Khan A, Brown D, Dhayagude N, He Z, Ni Y. Sources, production and commercial applications of fungal chitosan: A review. Journal of Bioresources and Bioproducts [Internet]. 2022 [Citado 28/08/2023]; 7(2): 85-98. Disponible en: https://www.sciencedirect.com/science/article/pii/S2369969822000020; Kou SG, Peters LM, Mucalo MR. Chitosan: A review of sources and preparation methods. International Journal of Biological Macromolecules [Internet]. 2021 [Citado 28/08/2023]; 169: 85-94. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0141813020351631; Azmana M, Mahmood S, Hilles AR, Rahman A, Arifin MAB, Ahmed S. A review on chitosan and chitosan-based bionanocomposites: Promising material for combatting global issues and its applications. International journal of biological macromolecules [Internet]. 2021 [Citado 28/08/2023]; 185: 832-48. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0141813021014604; Aranaz I, Alcántara AR, Civera MC, Arias C, Elorza B, Heras Caballero A, et al. Chitosan: An overview of its properties and applications. Polymers [Internet]. 2021 [Citado 28/08/2023]; 13(19): 3256. Disponible en: https://www.mdpi.com/2073-4360/13/19/3256; Baker WL, Tercius A, Anglade M, White CM, Coleman CI. A meta-analysis evaluating the impact of chitosan on serum lipids in hypercholesterolemic patients. Ann. Nutr. Metab [Internet]. 2009 [citado 18/8/2023]; 55(4): 368-74. Disponible en: https://karger.com/anm/article-abstract/55/4/368/40590/A-Meta-Analysis-Evaluating-the-Impact-of-Chitosan?redirectedFrom=fulltext 23. Tzeng HP, Liu SH, Chiang MT. Antidiabetic Properties of Chitosan and Its Derivatives. Mar Drugs [Internet]. 2022 [Citado 28/08/2023]; 20(12): 784. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782916/; Kou SG, Peters L, Mucalo M. Chitosan: A review of molecular structure, bioactivities and interactions with the human body and micro-organisms. Carbohydrate Polymers [Internet]. 2022 [Citado 14/08/2023]; 282: 119132. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0144861722000364; Hamedi H, Moradi S, Hudson SM, Tonelli AE, King MW. Chitosan based bioadhesives for biomedical applications: A review. Carbohydrate Polymers [Internet]. 2022 [Citado 14/08/2023]; 282: 119100. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0144861722000042; Jafernik K, Ładniak A, Blicharska E, Czarnek K, Ekiert H, Wiącek AE, et al. Chitosan-Based Nanoparticles as Effective Drug Delivery Systems—A review. Molecules [Internet]. 2023 [citado 14/08/2023]; 28(4): 1963. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959713/; Issahaku I, Tetteh IK, Tetteh AY. Chitosan and chitosan derivatives: Recent advancements in production and applications in environmental remediation. Environmental Advances [Internet]. 2023 [Citado 14/08/2023]; 11: 100351. Disponible en: https://www.sciencedirect.com/science/article/pii/S266676572300011X; Pal P, Pal A, Nakashima K, Yadav BK. Applications of chitosan in environmental remediation: A review. Chemosphere [Internet]. 2021 [citado 14/08/2023]; 266: 128934. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0045653520331313; Market analysis report. Chitosan Market Size, Share & Trends Analysis Report By Application (Pharmaceutical, Water Treatment, Cosmetics, Biomedical, Food & Beverage), By Region, And Segment Forecasts, 2023 – 2030 [Internet]. Grand View Research; 2023 [citado 18/8/2023]. Disponible en: https://www.grandviewresearch.com/industry-analysis/global-chitosan-market; Huq T, Khan A, Brown D, Dhayagude N, He Z, Ni Y. Sources, production and commercial applications of fungal chitosan: A review. Journal of Bioresources and Bioproducts [Internet]. 2022 [citado 14/08/2023]; 7(2): 85-98. Disponible en: https://www.sciencedirect.com/science/article/pii/S2369969822000020; Bauer JL, Villegas LF, Zucchetti A. Aplicaciones del quitosano en la agricultura, la industria y la salud: Applications of chitosan in agriculture, industry and health. South Florida Journal of Environmental and Animal Science [Internet]. 2022 [citado 14/08/2023]; 2(2): 37–45. Disponible en: https://ojs.southfloridapublishing.com/ojs/index.php/sfjeas/article/view/1335/1084; Shahrajabian MH, Chaski C, Polyzos N, Tzortzakis N, Petropoulos SA. Sustainable agriculture systems in vegetable production using chitin and chitosan as plant biostimulants. Biomolecules [Internet]. 2021 [citado 14/08/2023]; 11(6): 819. Disponible en: https://www.mdpi.com/2218-273X/11/6/819; Wang J, Zhuang S. Chitosan-based materials: Preparation, modification and application. Journal of Cleaner Production [Internet]. 2022 [citado 18/8/2023]; 355: 131825. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0959652622014354 34. Blázquez E, Sánchez R. Tratamiento de la obesidad en adultos: Liraglutida [Tesis]. Facultad de Farmacia de la Universidad complutense de Madrid; 2019 [citado 14/07/2023]. Disponible en: http://147.96.70.122/Web/TFG/TFG/Memoria/ELVIRA%20BLAZQUEZ%20MARCOS.pdf; Pittler MH, Abbot NC, Harkness EF, Ernst E. Randomized, double-blind trial of chitosan for body weight reduction. European Journal of Clinical Nutrition [Internet]. 1999 [citado 14/07/2023]; 53(5): 379-381. Disponible en: https://www.nature.com/articles/1600733; Jull AB, Mhurchu CN, Bennett DA, Dunshea‐Mooij CA, Rodgers A. Chitosan for overweight or obesity. Cochrane database of systematic reviews [Internet]. 2008 [citado 14/07/2023];(3): CD003892. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18646097/; Mhurchu CN, Poppitt SD, McGill AT, Leahy FE, Bennet DA, Lin RB, et al. The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults. International Journal of Obesity [Internet]. 2004 [citado 14/07/2023]; 28(9): 1149-1156. Disponible en: https://www.nature.com/articles/0802693; Fatahi S, Sayyari AA, Salehi M, Safa M, Sohouli M, Shidfar F, et al. The effects of chitosan supplementation on anthropometric indicators of obesity, lipid and glycemic profiles, and appetite-regulated hormones in adolescents with overweight or obesity: A randomized, double-blind clinical trial. BMC pediatrics [Internet]. 2022 [citado 14/07/2023]; 22(1): 527. Disponible en: https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-022-03590-x; Moraru C, Mincea MM, Frandes M, Timar B, Ostafe V. A meta-analysis on randomised controlled clinical trials evaluating the effect of the dietary supplement chitosan on weight loss, lipid parameters and blood pressure. Medicina [Internet]. 2018 [citado 14/07/2023]; 54(6): 109. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306953/; Garmendia Lorena F. El síndrome metabólico, ¿artificio o realidad? An. Fac. med [Internet]. 2020 [citado 14/07/2023]; 81(1): 92-98. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832020000100092&lng=es.; Fragozo MC. Síndrome metabólico: revisión de la literatura. Medicina & Laboratorio [Internet]. 2022 [citado 14/07/2023]; 26(1): 47-62. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8741857; https://revcmpinar.sld.cu/index.php/publicaciones/article/view/6164
-
10Academic Journal
المؤلفون: Belančić, Andrej, Javid, Farideh A
المصدر: Pharmacol Res Perspect ; ISSN:2052-1707 ; Volume:13 ; Issue:1
مصطلحات موضوعية: anti‐obesity drugs, drug development, endocannabinoid system, obesity
Relation: https://doi.org/10.1002/prp2.70056; https://pubmed.ncbi.nlm.nih.gov/39717881; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11667150/
-
11Academic Journal
المؤلفون: Kim N, Estrada J, Chow I, Ruseva A, Ramasamy A, Burudpakdee C, Blanchette CM
المصدر: ClinicoEconomics and Outcomes Research, Vol Volume 15, Pp 51-62 (2023)
مصطلحات موضوعية: obesity, anti-obesity drugs, health care costs, cost savings, health insurance, Medicine (General), R5-920, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
Relation: https://www.dovepress.com/the-relative-value-of-anti-obesity-medications-compared-to-similar-the-peer-reviewed-fulltext-article-CEOR; https://doaj.org/toc/1178-6981
-
12Academic Journal
المؤلفون: Yan Xue, Huimin Zou, Zhen Ruan, Xianwen Chen, Yunfeng Lai, Dongning Yao, Carolina Oi Lam Ung, Hao Hu
المصدر: Frontiers in Endocrinology, Vol 14 (2023)
مصطلحات موضوعية: obesity, anti-obesity drugs, cost-effectiveness, modeling, methodology, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
وصف الملف: electronic resource
-
13
المؤلفون: Koskinas, Konstantinos C., Van Craenenbroeck, Emeline M., Antoniades, Charalambos, Blueher, Matthias, Gorter, Thomas M., Hanssen, Henner, Marx, Nikolaus, McDonagh, Theresa A., Mingrone, Geltrude, Rosengren, Annika, 1951, Prescott, Eva B.
المصدر: EUROPEAN HEART JOURNAL. 45(38):4063-4098
مصطلحات موضوعية: Cardiology and Cardiovascular Disease, Kardiologi och kardiovaskulära sjukdomar, Anti-obesity drugs, Adipose tissue, Arrhythmia, Atherosclerosis, Bariatric interventions, Cardiovascular disease, Lifestyle interventions, Heart failure, Cardiovascular risk factors, Venous Thromboembolism, Valvular heart disease
URL الوصول: https://gup.ub.gu.se/publication/342660
-
14Academic Journal
المؤلفون: Katarzyna Cichoń, Małgorzata Chyćko, Julia Czarnota, Agata Kromer, Magdalena Alicja Zapała, Agnieszka Środoń, Joanna Wilk, Małgorzata Maria Cholewa, Agnieszka Gawryś, Monika Łapaj
المصدر: Journal of Education, Health and Sport, Vol 35, Iss 1 (2023)
مصطلحات موضوعية: Obesity, anti-obesity drugs, GLP-1 analogs, liraglutide, phentermine/topiramate, naltrexone/bupropion, Education, Sports, GV557-1198.995, Medicine
وصف الملف: electronic resource
-
15Academic Journal
المؤلفون: Jan Bieniasz, Konrad Dendys, Marcel Kazzi, Michał Puła, Marta Wychota
المصدر: Journal of Education, Health and Sport, Vol 13, Iss 4 (2023)
مصطلحات موضوعية: obesity, anti-obesity drugs, overweight, glucagon-like peptide-1, body weight reduction, combination obesity pharmacotherapy, Education, Sports, GV557-1198.995, Medicine
وصف الملف: electronic resource
-
16Academic Journal
المؤلفون: Cichoń, Katarzyna, Chyćko, Małgorzata, Czarnota, Julia, Kromer, Agata, Zapała, Magdalena Alicja, Środoń, Agnieszka, Wilk, Joanna, Cholewa, Małgorzata Maria, Gawryś, Agnieszka, Łapaj, Monika
المصدر: Journal of Education, Health and Sport; Tom 35 Nr 1 (2023); 94-112 ; Journal of Education, Health and Sport; Vol. 35 No. 1 (2023); 94-112 ; 2391-8306
مصطلحات موضوعية: Obesity, anti-obesity drugs, GLP-1 analogs, liraglutide, phentermine/topiramate, naltrexone/bupropion, lorcaserin, orlistat
وصف الملف: application/pdf
-
17Academic Journal
المؤلفون: Guglielmi, Valeria, Bettini, Silvia, Sbraccia, Paolo, Busetto, Luca, Pellegrini, Massimo, Yumuk, Volkan, Colao, Anna Maria, El Ghoch, Marwan, Muscogiuri, Giovanna
المساهمون: Guglielmi, V, Bettini, S, Sbraccia, P, Busetto, L, Pellegrini, M, Yumuk, V, Colao, Am, El Ghoch, M, Muscogiuri, G
مصطلحات موضوعية: Anti-obesity drugs, Comorbidities, Liraglutide, Naltrexone/bupropion, Semaglutide, Tirzepatide, Settore MED/09 - MEDICINA INTERNA
Relation: info:eu-repo/semantics/altIdentifier/pmid/37209215; info:eu-repo/semantics/altIdentifier/wos/WOS:000991161500001; volume:12; issue:2; firstpage:127; lastpage:146; numberofpages:20; journal:CURRENT OBESITY REPORTS; https://hdl.handle.net/2108/328363; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85159689990
-
18Academic Journal
المؤلفون: Mohamed M Ashour, Mostafa Mabrouk, Mohamed A Aboelnasr, Hanan H Beherei, Khairy M Tohamy, Diganta Das
مصطلحات موضوعية: Pharmacology and pharmaceutical sciences, anti-obesity drugs, active molecules, microneedles, nanoparticles, natural ingredients
Relation: 2134/24581814.v1; https://figshare.com/articles/journal_contribution/Anti-obesity_drug_delivery_systems_recent_progress_and_challenges/24581814
الاتاحة: https://figshare.com/articles/journal_contribution/Anti-obesity_drug_delivery_systems_recent_progress_and_challenges/24581814
-
19Academic Journal
المؤلفون: Davide Ialongo, Valeria Tudino, Merve Arpacioglu, Antonella Messore, Elisa Patacchini, Roberta Costi, Roberto Di Santo, Valentina Noemi Madia
المصدر: Pharmaceuticals; Volume 16; Issue 5; Pages: 730
مصطلحات موضوعية: caffeine, synergism, multidrug therapy, anti-inflammatory drugs, anticancer drugs, antimicrobial drugs, opioids, neurodegenerative diseases, antidiabetic drugs, anti-obesity drugs
وصف الملف: application/pdf
Relation: Natural Products; https://dx.doi.org/10.3390/ph16050730
الاتاحة: https://doi.org/10.3390/ph16050730
-
20Academic Journal
المؤلفون: Alejandro Barrios-Nolasco, Aarón Domínguez-López, Angel Miliar-García, Jorge Cornejo-Garrido, María Eugenia Jaramillo-Flores
المصدر: Molecules; Volume 28; Issue 9; Pages: 3801
مصطلحات موضوعية: obesity, high-fat diet, adipose tissue, inflammation, mRNA, cytokines, Tabebuia rosea, quercetin, anti-obesity drugs
جغرافية الموضوع: agris
وصف الملف: application/pdf
Relation: Medicinal Chemistry; https://dx.doi.org/10.3390/molecules28093801
Full Text Finder